A Perspective on Newly Emerging Proteolysis-Targeting Strategies in Antimicrobial Drug Discovery
Targeted protein degradation is a new aspect in the field of drug discovery. Traditionally, developing an antibiotic includes tedious and expensive processes, such as drug screening, lead optimization, and formulation. Proteolysis-targeting chimeras (PROTACs) are new-generation drugs that use the pr...
Saved in:
Main Authors: | Janarthanan Venkatesan (Author), Dhanashree Murugan (Author), Loganathan Rangasamy (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery of the first potent proteolysis targeting chimera (PROTAC) degrader of indoleamine 2,3-dioxygenase 1
by: Mingxing Hu, et al.
Published: (2020) -
Proteolysis-targeting chimeras and their implications in breast cancer
by: Angeles C. Tecalco-Cruz, et al.
Published: (2021) -
The clinical advances of proteolysis targeting chimeras in oncology
by: Hao Xie, et al.
Published: (2021) -
Synthesis and discovery of the first potent proteolysis targeting chimaera (PROTAC) degrader of AIMP2-DX2 as a lung cancer drug
by: BoRa Lee, et al.
Published: (2023) -
Proteostasis and Proteolysis
Published: (2022)